Danielle M Brander

7PUBLICATIONS
41CO-AUTHORS
Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 20, 2024
A phase 1 study of the CDK9 inhibitor voruciclib in relapsed/refractory acute myeloid leukemia and B-cell malignancies.

Matthew S Davids, Danielle M Brander, Yesid Alvarado-Valero

|Dec 08, 2024
Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA.

Mazyar Shadman, Talha Munir, Tadeusz Robak

|Nov 05, 2019
The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.

Toby A Eyre, Lindsey E Roeker, Christopher P Fox

|Nov 17, 2018
SET alpha and SET beta mRNA isoforms in chronic lymphocytic leukaemia.

Danielle M Brander, Daphne R Friedman, Alicia D Volkheimer

Pageof 2